Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 9
1978 10
1979 44
1980 31
1981 35
1982 66
1983 79
1984 77
1985 55
1986 65
1987 50
1988 30
1989 41
1990 24
1991 18
1992 13
1993 8
1994 17
1995 9
1996 6
1997 3
1998 6
1999 9
2000 6
2001 4
2002 3
2003 2
2004 4
2005 4
2006 5
2007 2
2008 2
2009 1
2010 4
2011 4
2012 3
2014 1
2015 1
2016 3
2017 1
2018 1
2019 3
2020 4
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Results by year

Filters applied: . Clear all
Page 1
Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM, Moellering RC Jr. Eliopoulos GM, et al. Ann Intern Med. 1982 Nov;97(5):755-60. doi: 10.7326/0003-4819-97-5-755. Ann Intern Med. 1982. PMID: 6215872 Review.
Three new broad-spectrum penicillins--azlocillin, mezlocillin, and piperacillin--will soon be available for clinical use. Azlocillin and piperacillin are more active than carbenicillin or ticarcillin against Pseudomonas aeruginosa. ...
Three new broad-spectrum penicillins--azlocillin, mezlocillin, and piperacillin--will soon be available for clinical use. Azlocill …
Azlocillin.
[No authors listed] [No authors listed] Drug Ther Bull. 1981 Aug 14;19(17):65-6. Drug Ther Bull. 1981. PMID: 7261905 No abstract available.
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Pothineni VR, Potula HSK, Ambati A, Mallajosyula VVA, Sridharan B, Inayathullah M, Ahmed MS, Rajadas J. Pothineni VR, et al. Sci Rep. 2020 Mar 2;10(1):3798. doi: 10.1038/s41598-020-59600-4. Sci Rep. 2020. PMID: 32123189 Free PMC article.
Moreover, the combination drug treatment of azlocillin and cefotaxime effectively killed doxycycline-tolerant B. burgdorferi. Furthermore, when tested in vivo, azlocillin has shown good efficacy against B. burgdorferi in mice model. ...
Moreover, the combination drug treatment of azlocillin and cefotaxime effectively killed doxycycline-tolerant B. burgdorferi. Further …
The acylampicillins: mezlocillin, piperacillin, and azlocillin.
Drusano GL, Schimpff SC, Hewitt WL. Drusano GL, et al. Rev Infect Dis. 1984 Jan-Feb;6(1):13-32. doi: 10.1093/clinids/6.1.13. Rev Infect Dis. 1984. PMID: 6369480 Review.
The new acylampicillin derivatives azlocillin, mezlocillin, and piperacillin have an increased activity against many gram-negative bacilli, especially Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa, when compared with the carboxypenicillins carbenic …
The new acylampicillin derivatives azlocillin, mezlocillin, and piperacillin have an increased activity against many gram-negative ba …
[Azlocillin pharmacokinetics].
Gagaeva EV, Danilova VI. Gagaeva EV, et al. Antibiot Khimioter. 1988 Feb;33(2):138-41. Antibiot Khimioter. 1988. PMID: 3288151 Review. Russian. No abstract available.
Penicillins (4th Generation).
[No authors listed] [No authors listed] 2020 Oct 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Oct 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643749 Free Books & Documents. Review.
Several others were used in the United States or Europe, but were abandoned or have been withdrawn (ticarcillin, carbenicillin, mezlocillin and azlocillin). Piperacillin is also available in combination with the beta-lactamase inhibitor tazobactam (taz" oh bak' tam), which …
Several others were used in the United States or Europe, but were abandoned or have been withdrawn (ticarcillin, carbenicillin, mezlocillin …
Azlocillin and serum uric acid.
Faris HM Jr, Potts DW. Faris HM Jr, et al. Ann Intern Med. 1983 Mar;98(3):414. doi: 10.7326/0003-4819-98-3-414_3. Ann Intern Med. 1983. PMID: 6830091 No abstract available.
[Clinical pharmacokinetics of azlocillin].
Singlas E, Haegel C. Singlas E, et al. Presse Med. 1984 Mar 29;13(13):788-96. Presse Med. 1984. PMID: 6231596 Review. French.
The pharmacokinetics of azlocillin have been studied in healthy subjects and in patients, in children and in adults, using different doses, either single or repeated. ...Azlocillin undergoes little metabolic degradation and its metabolites (penicilloates) amount to …
The pharmacokinetics of azlocillin have been studied in healthy subjects and in patients, in children and in adults, using different …
Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
Bergan T. Bergan T. J Antimicrob Chemother. 1983 May;11 Suppl B:101-14. doi: 10.1093/jac/11.suppl_b.101. J Antimicrob Chemother. 1983. PMID: 6352598 Review.
Cross-over studies on volunteers with several doses of azlocillin ranging from 1.0 to 5.0 g have shown that azlocillin is subject to dose dependent pharmacokinetics, the area under the serum curve becoming larger than expected as doses increase. ...In normal adults …
Cross-over studies on volunteers with several doses of azlocillin ranging from 1.0 to 5.0 g have shown that azlocillin is subj …
Azlocillin: in vitro studies of a new semisynthetic penicillin.
Stewart D, Bodey GP. Stewart D, et al. Antimicrob Agents Chemother. 1977 May;11(5):865-70. doi: 10.1128/AAC.11.5.865. Antimicrob Agents Chemother. 1977. PMID: 18083 Free PMC article.
The activity of azlocillin, a new semisynthetic penicillin, was determined against 582 clinical isolates of gram-negative bacilli and gram-positive cocci. ...Gram-positive cocci except penicillin G-resistant Staphylococcus aureus were susceptible to azlocillin. A …
The activity of azlocillin, a new semisynthetic penicillin, was determined against 582 clinical isolates of gram-negative bacilli and …
770 results